Sign inGet started

Graney Thomas

Insider CIK 1618275 · IRWD Chief Financial Officer · NTBL Director · VRTX Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NTBL Notable Labs, Ltd. A Award2024-05-082024-05-1040,247— $040,247SEC↗
NTBL Notable Labs, Ltd. A Award deriv2024-01-242024-01-269,753— $09,753SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2018-10-012018-10-021,076$193.24 $207.9K12,430SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award deriv2018-02-062018-02-0810,436— $010,436SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award2018-02-062018-02-084,500— $013,289SEC↗
VRTX VERTEX PHARMACEUTICALS INC S Sale2018-01-022018-01-03777$149.95 $116.5K8,789SEC↗
VRTX VERTEX PHARMACEUTICALS INC A Award2017-09-132017-09-159,566— $09,566SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2017-02-272017-03-01127,500— $0127,500SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award2017-02-272017-03-0121,250— $042,013SEC↗
IRWD IRONWOOD PHARMACEUTICALS I S Sale2017-02-222017-02-24457$16.94 $7.7K22,180SEC↗
IRWD IRONWOOD PHARMACEUTICALS I S Sale2017-02-222017-02-241,417$16.94 $24.0K20,763SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2016-03-012016-03-03105,000— $0105,000SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award2016-03-012016-03-0317,500— $022,637SEC↗
IRWD IRONWOOD PHARMACEUTICALS I S Sale2016-02-242016-02-26563$8.50 $4.8K5,137SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2015-03-162015-03-1834,100— $034,100SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award2015-03-162015-03-185,700— $05,700SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2014-09-022014-09-0450,000— $050,000SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2014-09-022014-09-0450,000— $050,000SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2014-09-022014-09-0450,000— $050,000SEC↗
IRWD IRONWOOD PHARMACEUTICALS I A Award deriv2014-09-022014-09-04150,000— $0150,000SEC↗